Type / Class
Equity / Common Stock, Par Value $0.0001 Per Share
Shares outstanding
23,267,064
Number of holders
139
Total 13F shares, excl. options
11,953,948
Shares change
+473,210
Total reported value, excl. options
$1,012,214,597
Value change
+$40,893,478
Put/Call ratio
99.34%
Number of buys
61
Number of sells
-51
Price
$84.74

Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) as of Q4 2021

166 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share as of Q4 2021.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 11,953,948 shares of 23,267,064 outstanding shares and own 51.38% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (1,499,213 shares), Avoro Capital Advisors LLC (1,425,000 shares), WELLINGTON MANAGEMENT GROUP LLP (1,320,795 shares), ARMISTICE CAPITAL, LLC (1,124,000 shares), VANGUARD GROUP INC (1,123,061 shares), BlackRock Inc. (949,527 shares), STATE STREET CORP (598,748 shares), Deep Track Capital, LP (500,000 shares), Rock Springs Capital Management LP (269,400 shares), and GEODE CAPITAL MANAGEMENT, LLC (220,018 shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.